Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Bullboard Posts
Post by bbzzzzon Apr 25, 2019 12:14pm
63 Views
Post# 29669872

Are you starting to feel "uncomfortable" stuck in the mud ..

Are you starting to feel "uncomfortable" stuck in the mud ..well , keep in mind you can reverse your vote if you voted BLUE by voting GOLD . ( see the vote Gold proxy documents ) 
 This new release by Medison re- ISS affirms what this proxy vote is all about .

management ( as per the current conflicted BOD )
U - underperformance  ( via conflict and inability to invest as per the Medison model)
Ddwindling confidence by shareholders that truly count -institutional 

 Will the implied value of Pharmascience drop when Knight is released by the strangle hold of the current conflicted board ?
 In the end in seems that Medison will prevail with over ten percent of shareholders on board toward a new horizon for Knight after this current vote. Another proxy vote may be round the corner. 
 Imagine a new nonconflicted board implementing already successful strategies employed by Medison in a conservative progressive manner.
 WE deserve better  ......you do not need to be stuck in the MUD.

tedz
Bullboard Posts